A detailed history of Glenmede Trust CO Na transactions in Eli Lilly & CO stock. As of the latest transaction made, Glenmede Trust CO Na holds 356,296 shares of LLY stock, worth $283 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
356,296
Previous 361,593 1.46%
Holding current value
$283 Million
Previous $327 Million 3.58%
% of portfolio
1.53%
Previous 1.67%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $4.09 Million - $5.09 Million
-5,297 Reduced 1.46%
356,296 $316 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $4.48 Million - $5.62 Million
-6,185 Reduced 1.68%
361,593 $327 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $16 Million - $21.4 Million
-27,028 Reduced 6.85%
367,778 $286 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $7.8 Million - $9.19 Million
-14,845 Reduced 3.62%
394,806 $230 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $10.8 Million - $14.8 Million
-24,757 Reduced 5.7%
409,651 $220 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $4.49 Million - $5.28 Million
-14,464 Reduced 3.22%
434,408 $149 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $1.63 Million - $1.89 Million
-5,057 Reduced 1.11%
448,872 $164 Million
Q3 2022

Nov 16, 2022

BUY
$296.48 - $337.87 $3.66 Million - $4.18 Million
12,360 Added 2.8%
453,929 $147 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $2.37 Million - $2.78 Million
-8,487 Reduced 1.89%
441,569 $143 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $10.2 Million - $12.7 Million
-43,477 Reduced 8.81%
450,056 $129 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $1.91 Million - $2.37 Million
-8,491 Reduced 1.69%
493,533 $136 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $1.81 Million - $2.23 Million
-8,177 Reduced 1.6%
502,024 $116 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $4.66 Million - $6.03 Million
-25,801 Reduced 4.81%
510,201 $117 Million
Q1 2021

May 18, 2021

BUY
$164.32 - $212.72 $298,569 - $386,512
1,817 Added 0.34%
536,002 $100 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $5.06 Million - $6.7 Million
38,809 Added 7.83%
534,185 $90.2 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $954,670 - $1.1 Million
-6,529 Reduced 1.3%
495,376 $73.3 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $2.34 Million - $2.82 Million
-17,168 Reduced 3.31%
501,905 $82.4 Million
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $31.9 Million - $39.5 Million
-298,422 Reduced 36.5%
519,073 $68.2 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $7.39 Million - $8.04 Million
-69,213 Reduced 7.81%
817,495 $91.4 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $8.57 Million - $10 Million
-77,311 Reduced 8.02%
886,708 $98.2 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $15.8 Million - $18.6 Million
-141,725 Reduced 12.82%
964,019 $125 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $2.39 Million - $2.68 Million
22,557 Added 2.08%
1,105,744 $128 Million
Q3 2018

Nov 15, 2018

SELL
$85.86 - $107.31 $1.55 Million - $1.94 Million
-18,033 Reduced 1.64%
1,083,187 $116 Million
Q2 2018

Aug 15, 2018

BUY
$75.7 - $86.88 $29.2 Million - $33.5 Million
385,266 Added 53.81%
1,101,220 $94 Million
Q4 2017

Feb 15, 2018

SELL
$81.94 - $87.89 $1.21 Million - $1.3 Million
-14,814 Reduced 2.03%
715,954 $60.5 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $56.3 Million - $62.5 Million
730,768
730,768 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.